DIA 2013 49th Annual Meeting Highlights

Not able to Attend DIA 2013 49th  Annual Meeting?

Now is your opportunity to listen to global thought leaders involved in the discovery, development, and life cycle management of medical products. Purchase the DIA 2013 49th Annual Meeting Live Learning Center NOW for $699 and access the recordings until July 9, 2014.

View Daily Highlights:

Monday, June 24 | Tuesday, June 25 | Wednesday, June 26 | Thursday, June 27 | Show Daily | Photo Library

Access Presentations



From the News...

DIA panel discusses collaboration to improve drug trials by Don Sieffert, Boston Business Journal

Here are 9 industry insiders at DIA 2013 to follow on Twitter by Stephanie Baum, MedCity News

Backlog to the Future: DIA 2013 in pictures
by Gareth Macdonald

Strange Bedfellows No More: EMA Moves Closer to Payers by William Looney

A Life Science Revolution is Happening Now by Rob Wright

DIA Delegates Welcome Cloudy Forecast by Gareth Macdonald

China/Taiwan Begin Shift To Regulatory Convergence by Zachary Brennan

DIA Wraps Up Successful Meeting, Looks Ahead To 50th Celebration by Ed Miseta

Can BYOD and Smartphones Move Clinical Trials Forward by Brian Eastwood

DIA 2013 Boston Recap from the BioClinica Exhibit by Jennifer Price

Delegation from Taiwan for the DIA 2013 49th Annual Meeting

49th Annual DIA Meeting Boston

Latest Pharma Exec Video

Monday, June 24 Highlights

Session 135 - Cooperation Among Regulators: Impact on Stakeholders

This afternoon, executive leadership from Health Canada, the European Medicines Agency (EU) and the US FDA return to the DIA Annual Meeting as Paul Glover, MBA (Assistant Deputy Minister, Health Products & Food Branch, Health Canada), Emer Cooke (Head of International and European Cooperation, European Medicines Agency) and FDA Commissioner Margaret A. Hamburg, MD, convene their second panel discussion on global regulatory collaboration.

Read More

Executives Promote Cooperation Among Regulators

Regulators Session See the Regulators in action in Monday's Session

Top executives from the regulatory agencies in Canada, the European Union, and the United States addressed an overflow crowd in a lively question and answer session on Cooperation Among Regulators: Impact on Stakeholders held Monday afternoon.

Read More

Volunteerism & Innovation Highlight Opening Plenary

Ling Su "DIA opened my eyes to a new world...we are more in tune to global issues."
- Ling Su, DIA President, In the Opening Plenary

This morning’s Opening Plenary featured elected DIA volunteer leadership, meeting program leadership, entertainment by Shapelogy, North America volunteer award winners from our global member network, and a keynote address from an innovative visionary whose career embodies our meeting theme, Dr. Daniel Kraft.

Read More

Daniel Kraft Dr. Daniel Kraft delivered an engaging, innovative Keynote Address.

Boston native and Incoming DIA President-Elect Minnie Baylor-Henry welcomed attendees to our DIA 2013 49th Annual Meeting by introducing a tribute to the spirit of “Boston Strong” in the wake of the Boston Marathon attack, and a video welcome by Massachusetts Governor Duval Patrick.

Read More

Welcome Patient Advocate Fellows

DIA’s Patient Advocate Fellowship Program supports the Annual Meeting participation of patient advocacy and patient group representatives, which provides opportunities for them to strengthen and support their collaborations with policy makers, health care professionals, industry representatives and other important groups. Twenty Advocates were selected to participate in this year’s program.

Read More in Monday's Show Daily | Tuesday's Show Daily | Wednesday's Show Daily

Take a walk through this year's DIA Annual Meeting. Provided by Patient Advocate Jack Whelan

Student Poster Sessions

Student Posters






We are pleased to announce our 2013 Student Poster Award Winners!

First Place: Evaluation of Cytochrome P450 2C19 Activity in Normal, Healthy Adult Subjects in a Western Indian Population Presented by: Harshavardhan Narendra Sant

Second Place: Challenges in Discovery and Development of Orphan Drugs and Possible Solutions: Indian Scenario Presented by: Priti Padmakar Pednekar

Third Place: The Registration of Biosimilar Medicines: The Case of Low Molecular Weight Heparines in View of the New CHMP Guideline
Presented by: Anna Magdalena Perelka

2013 Volunteer Award Winners

Freda Lewis-Hall, MD

Freda Lewis-Hall, MD, FAPA, recipient of the Distinguished Career Award

Because DIA members, volunteers and leadership work toward our shared vision around the world, DIA presents our annual volunteer awards at the annual meeting or flagship meeting in each region. Volunteers who have contributed greatly to DIA’s legacy in North America received their awards at a special dinner on Saturday, June 22.

Read More


DIA 2013 49th Annual Meeting Session Reports

How Can Translational Medicine Fill The Gaps in Life Sciences Industries? Session #123

Hot Topics in Statistics: Working Together Effectively to Transform Our Science Session #119

Key Multiplicity Issues in Clinical Trials Session #143

Translational Aspects from Preclinical Animal Toxicology Studies to Early Human Health Risk Assessment: Needs and Limitations Session #130

Today's Top Tweets
TwitterQuintiles: 'The smartphone has become a diagnostic device -changing the way we practice medicine'- D. Kraft #DIA2013 #QDIA
  TwitterEvaluatePharma: Life after the patent cliff? $230 billion of sales remain at risk from patent expiration #WorldPreview2013 #DIA2013 http://ow.ly/mk3dA
  TwitterParagon Solutions: #DIA2013: Check out this whitepaper by @consultparagon on Creating a Roadmap to Clinical Trial Efficiency http://ow.ly/mdIF6
  TwitterBBK Worldwide: While you're enjoying lunch, don't forget to text BOSTON STRONG to (617) 706-4000! For every text recv'd, BBK will donate $5. #DIA2013
  TwitterCovance: Don't miss Bill Leslie at #DIA2013 tomorrow at 10:15am. Innovative Partnering Models and Outsourcing Track. Sponsor & #CRO partnerships!

Tuesday, June 25 Highlights

“Big Data” Big Tuesday Topic

This morning’s session on Big Data: Impact on Innovation (Session 235, 10:15AM, Room 210ABC) opened with a Keynote Address by Dr. Michael Rosenblatt (Executive Vice President & Chief Medical Officer, Merck & Co., Inc.).

“We’re in the middle of a very exciting transformation in American and global healthcare, and big data are a major driver. Yet the term ‘big data’ and all it encompasses can seem mystifying."

Read More | Watch Highlights

Documentaries Spotlight Rare Disease Community

RARETo help Attendees hear the patient’s voice more clearly and understand the patient perspective, we are pleased to present two film documentaries, brought to you by The Kauffman Foundation, on Tuesday and Wednesday evening. Tuesday’s documentary is RARE.

Read More

DIA 2013 49th Annual Meeting Session Reports

Biomarkers for Drug Development: How are we dealing with the challenges?

Strategies for the Development and Registration of Antibody Drug Conjugates

First-in-Human Studies: How Much Complexity Is Too Much?

Top Tweets
Twitter Debra Barrette: Clinipace Worldwide is so excited to be at the Drug Information Association Conference in Boston! #DIA2013
  TwitterCraig Lipset: Wow. Just did rehearsal for handson "Trials of the Future" workshop. Come interact w/ the tech yr patients WILL use Wed 4p in 157C. #DIA2013
  Twitter Quintiles: 'If you have good governance in place then you can get great benefit out of data' - Boutin #DIA2013 #QDIA
   TwitterThe Avoca Group: RT @covance: Sponsor scope definition is critical to move forward and work collaboratively. #DIA2013   TwitterMicrosoft in Health: Do you know that you can GxP qualify the cloud with Microsoft? See what it is all about at  #DIA2013 booth 623. #pharma    
TwitterMedidata: #DIA2013: "Using Big Data to Design Smarter Studies" w/ @Medidata, @Genentech, @Quintiles Wed. 6/26 1:45pm Room #205C http://bit.ly/19nFkFO    TwitterIntralinks: Thanks for sharing @merck! "Big data is becoming increasingly important in a cost-restricted healthcare environment.”–M. Roseblatt #DIA2013    TwitterNPC: Attending #DIA2013 in Boston? Hear NPC Rsrch Dir Kimberly Westrich on stakeholders & #CER environment 8am 6/26 Rm151B http://bit.ly/1c1boij    TwitterErica Mercado: Great Q! How can we engage patients and advocacy groups in study design w/o violating confidentiality of the protocol? #DIA2013   
TwitterMerck: Heard at #DIA2013 CMO Roundtable: CMOs need to look beyond macro populations to focus on the individual, to advocate for the patient.   

Wednesday, June 26 Highlights

Advancing Alzheimer’s Innovation: A Call to Action

A visionary perspective on how industry and health authorities are working to help move towards a cure for Alzheimer's disease was provided by a distinguished panel of experts in this inaugural forum.

Watch Highlights

Meryl Comer Highlights Alzheimer's Forum

Meryl Comer Meryl Comer speaking in today's session

Meryl Comer, President of the Geoffrey Beene Foundation Alzheimer's Initiative, chaired today's session Advancing Alzheimer’s Innovation: A Call to Action, in which she discussed the global impact of Alzheimer's and the progress towards earlier detection and meaningful therapeutic intervention.

Watch Highlights

Documentaries Spotlight Rare Disease Community


To help Attendees hear the patient’s voice more clearly and understand the patient perspective, we are pleased to present two film documentaries, brought to you by The Kauffman Foundation, on Tuesday and Wednesday evening. Wednesday’s documentary is Here.Us.Now.

Read More

PHT Corporation and Lionbridge Life Sciences Presents Check to Boston Children's Hospital

DIA Donates to One Fund Boston

Final Count for One Fund Boston Contributions - Thank you DIA Attendees!

DIA 2014 50th Annual Meeting Call for Abstracts Opening Soon!

General Call for Abstracts Opens: August 1, Closes: September 9
Call for Student Poster Abstracts Opens: August 1, Closes: February 25
Call for Professional Poster Abstracts Opens: August 1, Closes March 3

Visit diahome.org/DIA2014 for more details

Top Tweets

TwitterRadCore Labs: Thank you @DrugInfoAssn for an incredible conference! See you next year in San Diego!! #DIA2013    TwitterQuintiles: #DIA2013 Daily Wrap Up: Day 3 [VIDEO] http://bit.ly/121luKj  #QDIA    TwitterCDISC: Ron Fitzmartin of #FDA: "All roads lead to #CDISC" (when speaking about the TA standards). #DIA2013 
TwitterRob Wright: Satlin describing role of simulation in the Bayesian Alzheimer's study design #DIA2013
  TwitterGlobalEpi Research: @teaminspire Great talks by @BrianLoew and the rest of the speakers in the #rarediseases track at #DIA2013    TwitterPharmalinkConsulting: @DrugInfoAssn A big thank you to everyone who helped make #DIA2013 very successful from everyone here @Pharmalink pic.twitter.com/FkYOPPmAOS 

Thursday, June 27 Highlights

CDER Town Hall Part 1 of 2

Show Daily

Issue #1 Issue #2 Issue #3 Issue #4

DIA 2013 49th Annual Meeting Photo Library

Tribute to Boston at the DIA 2013 49th Annual Meeting

© 2018 DIA